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Beyond Muscle: The Effects of Creatine 
Supplementation on Brain Creatine 
The ergogenic and therapeutic effects of increasing muscle creatine by supplementation are well-
recognized. It appears that similar benefits to brain function and cognitive processing may also 
be achieved with creatine supplementation, however research in this area is more limited, and 
important knowledge gaps remain. The purpose of this review is to provide a comprehensive 
overview of the current state of knowledge about the influence of creatine supplementation on 
brain function in healthy individuals. It appears that brain creatine is responsive to 
supplementation, however higher, or more prolonged dosing strategies than those typically used 
to increase muscle creatine, may be required to elicit an increase in brain creatine. The optimal 
dosing strategy to induce this response, is currently unknown, and there is an urgent need for 
studies investigating this. When considering the influence of supplementation strategies on 
cognitive processes, it appears that creatine is most likely to exert an influence in situations 
whereby cognitive processes are stressed, e.g. during sleep deprivation, experimental hypoxia, or 
during the performance of more complex, and thus more cognitively demanding tasks. Evidence 
exists indicating that increased brain creatine may be effective at reducing the severity of, or 
enhancing recovery from mild traumatic brain injury, however, only limited data in humans are 
available to verify this hypothesis, thus representing an exciting area for further research. 
Keywords: Phosphorylcreatine; cerebral energy metabolism; dietary supplement; cognition; 
concussion 
Highlights 
• The brain is a highly metabolically active organ, and thus requires a constant energy 
supply. A high creatine content may theoretically enhance brain function, through 
facilitating rapid energy provision during times of accelerated ATP turnover. 
• The brain does appear to be amenable to creatine supplementation. Optimal dosing 
protocols, particularly in healthy individuals, remain unknown although higher and/or 
more prolonged dosing protocols than those used to increase muscle creatine seem 
necessary. 
• Creatine supplementation is most likely to positively impact cognitive processing during 
stressful situations, whereby brain creatine content is chronically or acutely suppressed. 
• Preventive creatine supplementation may protect brain function in the event of acute 
stressors, such as sleep deprivation, acute hypoxia, exhaustive exercise or mTBI. Chronic 
reductions in brain creatine occur in a number of conditions. Therapeutic creatine 
supplementation restores brain creatine content, thus facilitating recovery of usual brain 
function. 
Introduction 
The effects of creatine monohydrate supplementation on muscle creatine levels and exercise 
performance in young adults have been well studied and extensively reviewed (reviewed in 
Branch, 2003; Heaton et al., 2017; Rawson & Volek, 2003; Rawson, Miles, & Larson-Meyer, 
2018). Further, the potential benefits of creatine monohydrate supplementation in older adults 
(reviewed in Candow, Chilibeck, & Forbes, 2014; Chilibeck, Kaviani, Candow, & Zello, 2017; 
Devries & Phillips, 2014; Gualano, Rawson, Candow, & Chilibeck, 2016; Rawson & Venezia, 
2011), and patient populations (reviewed in Bender & Klopstock, 2016; Gualano, Roschel, 
Lancha, Brightbill, & Rawson, 2012) have also been thoroughly researched and well 
documented. The ingestion of about 20 g of creatine monohydrate per day (four 5 g servings) for 
about 5 days (or 3-5 g per day for about 30 days), first noted by Harris, Söderlund, and Hultman 
(1992) and Hultman, Söderlund, Timmons, Cederblad, and Greenhaff (1996), increases muscle 
creatine by about 20%. Larger increases in muscle creatine in response to creatine monohydrate 
ingestion can be obtained by combining the supplement with exercise, carbohydrate, or 
carbohydrate/protein combinations, although maximal creatine accumulation in mid-to-long-term 
(i.e. weeks to months) seems not to be affected by any of these factors (Hultman et al., 1996). 
Creatine's primary mechanistic role is to facilitate rapid energy provision during times of 
accelerated ATP degradation, which is achieved through transferring an N-phosphoryl group 
from phosphorylcreatine to ADP, a reaction which is reversibly catalysed by creatine kinase 
(CK). Additionally, the Cr-PCr system is proposed to act as a 'spatial energy buffer' whereby the 
different CK isoforms link the sites of ATP generation (i.e. the mitochondria), to sites of high 
ATP use (e.g. the sarcomere) (Greenhaff, 2001; Sahlin & Harris, 2011). Subsequently, creatine 
facilitates the maintenance of ATP homeostasis in tissues with high energy turnover, and 
supplementation has been shown to enhance performance of brief, high-intensity exercise, 
typically lasting less than 30 seconds, and resistance exercise performance (reviewed in Branch, 
2003; Rawson & Volek, 2003). 
As with muscle creatine, increasing brain creatine may confer benefits to athletes, non-athletes, 
older adults, and certain patient populations (reviewed in Gualano et al., 2012; Gualano et al., 
2016; Rae & Broer, 2015; Rawson & Venezia, 2011). Relative to skeletal muscle, only a small 
percentage of total body creatine is in the brain (i.e. <5%) (Andres, Ducray, Schlattner, 
Wallimann, & Widmer, 2008). However, the brain is highly metabolically active, and, as in 
skeletal muscle, brain creatine is essential for energy production. This is corroborated by several 
lines of evidence, including: (i) the presence of CK isoforms in the central nervous system, (ii) 
the extensive mental disorders provoked by brain creatine depletion in creatine-deficient 
syndromes, and (iii) the partial reversal of these by creatine monohydrate supplementation 
(Kaldis, Hemmer, Zanolla, Holtzman, & Wallimann, 1996; Salomons et al., 2003; Stöckler et al., 
1994). Indeed, the effects of creatine monohydrate supplementation on brain creatine and 
cognitive processing have become of interest to researchers and practitioners in a wide range of 
fields, from health to elite performance. 
The influence of creatine supplementation on cognitive performance may occur due to a number 
of potential mechanisms. The brain is a highly metabolically active organ, responsible for 20% 
of basal metabolism, despite accounting for just 2% of body mass. The brain is therefore reliant 
on a constant energy supply in order to fulfil all functions, including maintenance of electrical 
membrane potentials, action potential propagation and PNS and CNS signalling (Gualano, 
Artioli, Poortmans, & Lancha Junior, 2010; Turner, Byblow, & Gant, 2015). During times of 
accelerated brain ATP turnover (as may be the case during the performance of complex cognitive 
tasks), or disrupted bioenergetic ATP turnover (as occurs during situations such as hypoxia, 
sleep deprivation and various neurological conditions), creatine supplementation facilitates a 
more constant regeneration of ATP in the brain, thereby enhancing the ability to perform 
cognitive tasks. For example, Hammett, Wall, Edwards, and Smith (2010) reported a 16% 
reduction in Blood Oxygen Level Dependent (BOLD) amplitude after supplementing a group of 
young healthy adults with creatine. This attenuation of BOLD response was accompanied by an 
improved performance on various cognitive tests, and the authors hypothesized that their 
supplementation protocol likely increased cerebral phosphorylcreatine, thereby reducing 
metabolic demand and enhancing neural activity (Hammett et al., 2010). In support of this, 
Watanabe, Kato, and Kato (2002) used near-infrared spectroscopy to measure cerebral 
oxygenated and deoxygenated haemoglobin, and reported a reduction in oxygenated Hb, and 
elevation of deoxygenated Hb during the first part of a serial calculation task, along with a 
reduction in a mental fatigue index during the latter part of the cognitive test. Interestingly, 
however, Turner, Byblow, et al. (2015) reported that the magnitude of increase in brain creatine 
in their study did not predict the extent to which hypoxia-induced neurocognitive deficits were 
corrected in the creatine group. The authors suggested that the neuroprotective influence of 
creatine supplementation may occur, at least in part, due to non-energetic, and potential 
neuromodulatory mechanisms (Turner, Byblow, et al., 2015). Potential mechanisms through 
which this may be achieved include protecting against oxidative stress or mitochondrial 
membrane potential; Na+/K+-ATPase and/or CAMKII/CREB regulation (Souza et al., 2012). 
These mechanisms are as yet poorly understood, however, and further research is required to 
more fully investigate the potentially pleiotropic influence of creatine on brain function and 
cognitive processing. 
The focus of this review is to describe the factors that affect brain creatine, including 
supplementation, and to determine if creatine monohydrate supplementation can improve 
cognitive processing or offer other benefits. It is important to identify that an ever-increasing 
body of evidence suggests the potential of creatine as a therapeutic agent in conditions whereby 
brain creatine is chronically suppressed, e.g. depression, schizophrenia, panic disorder, creatine 
deficiency syndromes caused by inborn errors of metabolism, and following a brain injury such 
as a concussion (reviewed in Allen, 2012; Kreider et al., 2017; Rae & Broer, 2015; Rawson 
et al., 2018; Rawson & Venezia, 2011), or to protect against the negative consequences of 
senescence (reviewed in Gualano et al., 2016). As these topics have been reviewed in detail 
elsewhere, the current review focuses on the use of creatine supplementation to enhance brain 
function in healthy individuals. The bulk of the research on safety and efficacy has been 
conducted on creatine monohydrate, and as other types of creatine supplements have not been as 
well studied, and so, unless otherwise specified, creatine supplementation will refer to creatine 
monohydrate supplementation in this article. 
Factors influencing brain creatine: a brief overview 
Creatine is a naturally occurring nutrient that is consumed in the diet, and synthesized in the 
liver, pancreas, and kidneys (Walker, 1979). Dietary creatine intake varies, but, in meat-eaters, is 
probably about 1-4 g·d−1. In foods, creatine is mostly localized to meat and fish at a 
concentration of about 3-5 g·kg−1 raw meat. Skeletal muscle, which contains about 95% of body 
creatine, cannot synthesize creatine, and so it is readily able to take up endogenously produced, 
supplemental, and/or dietary creatine. Unlike skeletal muscle, the brain can synthesize creatine, 
and does not appear to rely on endogenous production from other organs (e.g. liver, pancreas, 
kidneys) or exogenous dietary sources (Braissant, Bachmann, & Henry, 2007). There is some 
indication that muscle creatine decreases with age, but this could also be a product of decreased 
physical activity, and not aging per se. It appears that muscle creatine does not increase with 
exercise training, but does decrease when research volunteers are placed on a vegetarian (i.e. low 
creatine) diet (Lukaszuk et al., 2002; Lukaszuk, Robertson, Arch, & Moyna, 2005). Brain 
creatine may also decrease with age (Laakso et al., 2003), but age-related decreases in brain 
creatine could also result from reduced brain activity or disease. In fact, it was recently shown 
that apparently healthy elderly and young individuals show comparable levels of brain 
phosphorylcreatine (Solis et al., 2017). Yazigi Solis et al. (2014) reduced muscle 
phosphorylcreatine in vegetarians, but no differences in brain phosphorylcreatine between 
vegetarians and omnivores, indicating that brain creatine is not influenced by habitual dietary 
creatine intake. 
Effects of creatine supplementation on brain creatine 
It is commonly accepted that a loading phase of 5 g (or ∼0.3 g·kg−1) ingested 4 times daily for 5-
7 days should increase muscle creatine and PCr by approximately 20-40%, while continued 
ingestion of 3-5 g·day−1 allows maintenance of these elevated creatine levels (Kreider et al., 
2017). The dosing strategy required to optimally increase brain creatine levels has yet to be 
established, and this is largely due to a limited dataset that directly measures the influence of 
supplementation on brain creatine content. While direct measurement of muscle creatine and 
phosphorylcreatine can be accomplished through analysis of tissue obtained from muscle 
biopsies, assessment of brain creatine is more difficult. Direct measurement of brain creatine and 
phosphorylcreatine pre- and post-creatine supplementation can be accomplished in animals, but 
species differences in creatine uptake reveal the complications of generalizing data from this 
experimental model to humans (Ipsiroglu et al., 2001; Kreider, 2003; Nicastro et al., 2012; 
Tarnopolsky et al., 2003). Brain creatine can be assessed using proton or phosphorous nuclear 
magnetic resonance spectroscopy (H1-NMR and P31-NMR, respectively), but this is costly, not 
widely available, and, typically, labs can either measure total brain creatine (with H1-NMR) or 
brain phosphorylcreatine (with P31-NMR), but not both, due to time, funds, or technical 
constraints. These complications may have contributed to the fact that only a small number of 
human studies are available in which brain creatine levels were measured pre- and post-creatine 
supplementation. In addition, brain creatine content seems to be highly site-specific (reviewed by 
Rawson & Venezia, 2011), which renders it difficult to directly compare studies measuring 
creatine in different brain areas. 
Table I describes the effects of creatine supplementation on brain creatine. As few studies are 
available in healthy individuals, we included reference to studies conducted in clinical 
populations. The available studies demonstrate that both brain creatine and phosphorylcreatine 
appear to increase in response to supplementation, although this appears to be a smaller increase 
than what is commonly seen in skeletal muscle (about 10% vs. about 20%). Several factors could 
explain the difference in tissue creatine uptake between muscle and brain. In the brain, there 
could be a compensatory response to creatine feeding in which brain creatine synthesis decreases 
and brain creatine normalizes despite supplementation. This is line with the emerging hypothesis 
that brain creatine, as compared to muscle, is less reliant on exogenous creatine ingestion 
(Braissant et al., 2007; Merege-Filho et al., 2017; Solis et al., 2017; Yazigi Solis et al., 2014). In 
fact, the key enzymes involved in creatine biosynthesis (i.e. arginine:glycine amidinotransferase 
and S-adenosyl-l-methionine:N-guanidinoacetate methyltransferase) are present in astrocytes, 
neurons, and oligodendrocytes, therefore these cells are able to synthesize their own creatine 
(Andres et al., 2008; Braissant et al., 2007). On the other hand, the brain permeability to 
circulating creatine appears to be limited, likely due to the absence of creatine transporter 
expression in the astrocytes involved in the blood-brain barrier (Beard & Braissant, 2010). 
Effects of creatine supplementation on brain creatine and phosphorylcreatine 
Population Supplementation protocol 
Change in brain 
creatine 
Reference 
6 adults (2 M; 4 W) Age 
26 yr 
Single 20 g dose 




Dechent, et al. 
(1999) 
6 adults (2 M; 4 W) Age 
26 yr 
20 g·d−1 for 28 d 




Dechent et al. 
(1999) 
10 men (creatine group) 
Age 23 yr 
0.3 g·kg−1·d−1 for 7 d; then 
0.03 g·kg−1 d−1 for 7 d 
↑ PCr 3.9% 
Lyoo et al. 
(2003) 
12 men (creatine group) 
Age 23 yr 
20 g·d−1 for 5 d No change 
Wilkinson 
et al. (2006) 
12 adults (7 M; 5 W) 
Age 32 yr 
20 g·d−1 for 7 d 
↑ creatine 5.2% 






5 female adolescents 
with MDD Age 13-18 yr 
4 g·d−1 for 8 wk ↑ 6.4%   
Kondo et al. 
(2011) 
14 adult female 
amphetamine users with 
depression Age 37 yr 
5 g·d−1 for 8 wk ↑ PCr 4.4% 
Hellem et al. 
(2015) 
15 adults (10 M; 5 W) 
Age 31 yr 
20 g·d−1 for 7 d ↑ creatine 9.2% 
Turner, 
Byblow, et al. 
(2015) 
15 adults (10 M; 5 W) 
Age 31 yr 




22 adolescent females 
with SSRI-resistant 
MDD Age 17 yr 
2 g·d−1 for 8 wk (n = 7) 4 
g·d−1 for 8 wk (n = 8) 10 
g·d−1 for 8 wk (n = 7) 
↑ PCr 4.6% (2 g 
group) ↑ PCr 4.1% 
(4 g group) ↑ PCr 
9.1% (10 g group) 
Kondo et al. 
(2016) 
35 children (creatine 
group) Age 11 
0.3 g·kg−1 for 7 d No effect 
Merege-Filho 
et al. (2017) 
15 children 16 adults 17 
older adults (creatine 
groups) Age 11, 30, and 
72 yr 
0.3 g·kg−1·d−1 for 7 d 
ΔPCr −0.7 to +3.9% 
(↑ muscle PCr +10.3 
to 27.6%) 
Solis et al. 
(2017) 
PCr = phosphorylcreatine; SSRI = selective serotonin reuptake inhibitor; MDD = major 
depressive disorder. 
This may explain how some studies report no increase, or even a decrease in brain creatine 
following supplementation, but this is still speculative. Only short-term data are available, so it is 
unknown if increased brain creatine resulting from supplementation can be maintained, as is the 
case with muscle creatine. If the brain is resistant to exogenous creatine, it would make sense 
that a higher dose, maintained for a longer period of time, as shown by Dechent et al. (1999), 
would be needed to increase and maintain elevated brain creatine levels. Several groups have 
demonstrated regional differences in both basal brain creatine and in the response to 
supplementation, highlighting that the ideal sampling area has not been determined. Finally, only 
one study is available that simultaneously assessed brain and muscle creatine, pre- and post-
supplementation (Solis et al., 2017). In this investigation, brain phosphorylcreatine did not 
increase as a result of supplementation (range = −0.7 to +3.9), but muscle phosphorylcreatine 
increased (+10.3 to +27.6%) similarly to previous studies. This study ultimately suggests that the 
recommended dose of creatine effective to increase skeletal muscle creatine is not the same as 
the dose needed to increase brain creatine, with the latter remaining unknown. It does appear that 
larger and/or more sustained creatine doses may be required to elicit an increase in brain creatine 
content, and thus, identification of alternative dietary strategies to increase brain creatine content 
is of interest. Recently, guanidinoacetic acid (GAA, 3 g·day−1), a naturally occurring creatine 
precursor, was reported to have a superior influence on brain creatine content when compared to 
an equimolar dose of creatine (Ostojic, Ostojic, Drid, & Vranes, 2016), although it is important 
to note that this finding was based on a preliminary investigation of just five participants. The 
safety and efficacy of GAA supplementation have yet to be ascertained, therefore, general 
consumption outside of a controlled research setting cannot currently be recommended. Finally, 
little can be concluded about the magnitude of changes in brain creatine/phosphorylcreatine in 
response to supplementation, since the vast majority of studies did not report individual data or 
the typical error of measurement (for the magnetic resonance spectroscopy (MRS) method), 
which precludes the determination of within- and between-subject variability and the rate of 
responsiveness to creatine supplementation, which is known for muscle creatine (∼20-30% are 
non-responders; Greenhaff et al., 1993; Harris et al., 1992), but not for brain creatine. 
Effects of creatine supplementation on cognitive processing 
Research investigating the effect of creatine supplementation on cognitive performance in 
healthy humans is summarized in Table II. It is clear that creatine supplementation does have the 
potential to influence facets of brain function and cognitive processing in a number of models 
(Hammett et al., 2010; Ling et al., 2009; McMorris et al., 2006; McMorris, Harris, et al., 2007; 
Rae, Digney, McEwan, & Bates, 2003; Turner, Byblow, et al., 2015; Watanabe et al., 2002). 
However, wide variation in tests of cognitive function, dosing protocol, study populations and 
statistical approaches render it difficult to conclusively summarize and interpret the available 
evidence, meaning that only broad inferences can be made at this time. It seems that creatine is 
most likely to exert an influence in situations whereby cognitive processes are stressed, e.g. 
during sleep deprivation (McMorris et al., 2006; McMorris, Harris, et al., 2007), or experimental 
hypoxia (Turner, Byblow, et al., 2015). Additionally, it seems that more complex or demanding 
cognitive tests, such as central executive function, are more amenable to supplementation 
(McMorris et al., 2006; McMorris, Harris, et al., 2007) likely due to activation of larger brain 
areas with increased energy requirement and subsequently elevated requirement for ATP 
regeneration. There is, however, a lack of consistency in the cognitive test response to creatine 
supplementation, which makes it difficult to decipher the cognitive domains most susceptible to 
supplementation. For example, McMorris et al. (McMorris et al., 2006; McMorris, Harris, et al., 
2007) conducted 2 complementary studies investigating the effect of creatine supplementation on 
cognitive function following 24 (McMorris et al., 2006) and 36 (McMorris, Harris, et al., 2007) 
hours of sleep deprivation. Both studies showed a positive effect of supplementation on at least 
one of the cognitive tests conducted, however different tests were impacted in each study. This 
was surprising, given that the same supplementation protocol and cognitive tests were used, 
while the study population were from a similar background (i.e. healthy young men and women). 
Another surprising finding from these studies, was that the study which used a longer period of 
sleep deprivation (24 vs. 36 hours), actually showed a lesser impact of creatine on cognitive 
function. One potential explanation for these differing results is the intensity of exercise 
employed in each study. Moderate intensity exercise was intermittently performed throughout 
the 36-hour sleep deprivation trial, while mild-intensity exercise was performed during the 24-
hour trial. Non-exhaustive exercise, which does not induce dehydration, has previously been 
reported to have a positive influence on cognition (Tomporowski & Ellis, 1986), and it is 
possible that the moderate intensity exercise used within the latter design by McMorris, Harris, 
et al. (2007) actually acted to protect cognitive processes against the negative influence of sleep 
deprivation, thus ameliorating the concomitant influence of creatine supplementation. This is an 
important point for authors investigating the influence of creatine supplementation on cognitive 
function in active individuals to consider, and the potentially confounding influence of exercise 
(which may, in fact, be positive or negative), should be appropriately controlled for within the 
study design. 
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The evidence supporting the use of creatine supplementation to enhance cognitive processing in 
unstressed, healthy individuals is contrasting, with a positive influence reported by some 
(Hammett et al., 2010; Ling et al., 2009; Rae et al., 2003; Watanabe et al., 2002), but not others 
(Alves et al., 2013; Merege-Filho et al., 2017; Rawson et al., 2008). Some evidence exists 
suggesting that vegetarians may differentially respond to creatine supplementation when 
compared to meat-eaters. Rae et al. (2003) reported that cognitive performance was improved 
after a group of healthy, unstressed vegans and vegetarians supplemented with 5 g·day−1 of 
creatine monohydrate for 6 weeks, indicating that vegetarians may be more susceptible to the 
effects of creatine than meat-eaters, although a control group of meat-eaters would be required to 
confirm this. The hypothesis is however partially supported by Benton and Donohoe (2011) who 
reported that creatine supplementation resulted in a greater effect on memory in a group of 
vegetarians compared with meat-eaters. The results of this particular study should be interpreted 
with caution, as the vegetarian group did not actually improve performance following 
supplementation, and the reported post-supplementation difference was due to a reduction in 
performance in the meat-eaters. Nonetheless, collectively these two studies do appear to indicate 
a differential response between meat-eaters and vegetarians and it is plausible to hypothesize that 
non-meat-eaters, who have lower exogenous creatine intakes are more susceptible to the 
cognitive performance enhancing effects of creatine supplementation. This hypothesis is not 
however supported by the findings of Yazigi Solis et al. (2014), who reported similar brain 
creatine content in meat-eaters and vegetarians, and who concluded that brain creatine content 
relies on endogenous synthesis rather than dietary intake. Further research is therefore required 
to more fully investigate if meat-eaters and vegetarians do in fact have a different neurological 
response to creatine supplementation. 
Whether or not potential cognitive improvements brought about through creatine 
supplementation can transfer to performance enhancements in the field is particularly relevant to 
athletes. This was investigated by Cook et al. (2011), who reported that sleep deprivation 
induced reductions in rugby throwing accuracy were attenuated by acute creatine 
supplementation (Cook et al., 2011). This study provides promising data of a potential 
enhancement of skilled motor performance under a stressful condition, in response to creatine 
supplementation. These results are not supported by other studies, however, which reported no 
impact of creatine supplementation on soccer passing accuracy (Cox, Mujika, Tumilty, & Burke, 
2002; Hamid, Rahnama, Moghadasi, & Ranjbar, 2012). There are a number of potential 
explanations for this ambiguity in study findings. For example, the rugby passing test used by 
Cook et al. (2011) was time-constrained, while the soccer passing accuracy test was not, and is it 
plausible that the added pressure of time-constraint increased the cognitive demand required, 
thus rendering it more amenable to creatine supplementation. A more likely explanation, 
however, is that the rugby players participating in the study by Cook et al. (2011) were sleep 
deprived, adding weight to the hypothesis that creatine supplementation is most likely to exert its 
ergogenic effect when cognition is stressed. It is important to note that none of the studies 
investigating the effect of creatine supplementation on skilled motor performance provided data 
on brain creatine levels, and it is questionable whether the acute protocol used by Cook et al. 
(2011) would have resulted in increased brain creatine content, meaning that the mechanisms 
underpinning the improved performance reported in this study are uncertain. 
Very few studies have simultaneously reported data related to the influence of creatine 
supplementation on brain creatine levels and cognitive function, making it difficult to ascertain 
whether the results attained are directly due to increased brain creatine levels. As discussed in the 
previous section, it appears likely that the brain is capable of exogenously maintaining adequate 
brain creatine levels, and that either higher dosing protocols (Solis et al., 2017) or increased 
creatine requirement due to the influence of a stressor may be required in order to exert an 
influence. In support of this, Merege-Filho et al. (2017), recently investigated the influence of 
creatine supplementation (0.3 g·kg−1·day−1 creatine monohydrate for 7 days) on brain creatine 
levels and cognitive function in a group of healthy children aged 10-12 years, and reported no 
difference to either brain creatine content or cognitive function as a result of supplementation. 
The authors concluded that the lack of improvement to cognitive function may have been due to 
the lack of increase in brain creatine content, and indicated that creatine loading may only 
produce a functional effect on cognition under conditions of brain bioenergetic perturbation 
(Merege-Filho et al., 2017). Although most of the aforementioned studies investigating the 
influence of creatine supplementation on cognitive function did not directly investigate whether 
or not brain creatine levels increased, the data from these two studies (Merege-Filho et al., 2017; 
Solis et al., 2017) indicate that the lack of effect reported by many studies summarized in this 
review (Alves et al., 2013; Merege-Filho et al., 2017; Rawson et al., 2008) may be due, at least 
in part, to the inadequacy of the dosing strategy to increase brain creatine levels. 
Mild traumatic brain injury: is there a protective role for brain creatine? 
A nutritional intervention that might reduce severity of, or enhance recovery from, mild 
traumatic brain injury (mTBI), or concussion, would be highly valued in both the general and 
athletic populations. Following a mTBI there is a reduction in brain creatine (Vagnozzi et al., 
2013) and a hypometabolic state. It is sensible that creatine supplementation, and subsequent 
increase in brain creatine, might offset these negative changes in energy status. Further, mTBI is 
characterized by numerous undesirable changes that could be lessened through creatine 
supplementation, including membrane disruption leading to calcium influx, nerve damage, 
mitochondrial dysfunction, oxidative stress, and inflammation (reviewed in Barrett, McBurney, 
& Ciappio, 2014; Dean, Arikan, Opitz, & Sterr, 2017). Few experimental data in humans are 
available, but two open-label creatine supplementation trials show improvements in cognition, 
communication, self-care, personality, and behaviour, and reductions in headaches, dizziness, 
and fatigue in children with TBI (Sakellaris et al., 2006; Sakellaris et al., 2008). Additionally, 
Turner and colleagues (Turner, Byblow, et al., 2015) showed increased brain creatine and 
cognitive processing during oxygen deprivation, a model that mimics the effects of mTBI. 
Although there are clearly species differences in response to creatine supplementation, animal 
data do indicate that creatine supplementation prior to TBI decreases damage by as much as 50% 
(Sullivan, Geiger, Mattson, & Scheff, 2000). Though few data available, and much more data are 
needed, the benefits of creatine supplementation could include reduced severity of, or enhanced 
recovery from, mTBI (reviewed in Kreider et al., 2017; Rawson et al., 2018). 
Concluding remarks, perspectives and practical recommendations 
Even though the role of creatine supplementation on brain functioning is promising, important 
scientific gaps remain that must be addressed (Box 1). First, bioavailability studies are necessary 
to show the optimal creatine supplementation protocol able to induce the greatest increases in 
brain creatine/phosphorylcreatine content. Evidence suggests that the blood-brain barrier is an 
obstacle for circulating creatine, which may require larger doses and/or longer protocols to 
increase brain creatine as compared to muscle. In fact, the broad spectrum of creatine 
supplementation studies that span different dosing protocols (e.g. high-dose short-term, low dose 
longer-term), co-ingestion of other nutrients/compounds (e.g. carbohydrate, protein, insulin), 
different populations (e.g. vegetarians, elderly, patients, athletes) is unavailable for brain creatine 
adaptations. In addition, the sensitivity and reliability of NMR techniques used for measuring 
creatine/phosphorylcreatine in different areas of brain need to be determined, so that the precise 
magnitude of change in brain creatine, induced by creatine supplementation, can be ascertained 
at the individual level (Swinton, Hemingway, 2018). Studies combining the assessments of 
cognitive function and brain creatine levels are also relevant as they provide the ability to 
correlate changes in these two parameters, which in theory should occur in parallel. Ideally, 
therefore, creatine content should be assessed in specific brain areas involved in expected 
cognitive functions (e.g. measurement of brain creatine in hippocampus along with assessment of 
memory), allowing the mapping between brain creatine and cognitive processing in the context 
of supplementation. 
Summary and Future directions 
What is already known: 
Creatine supplementation may increase brain creatine content, particularly in creatine-depleted 
conditions (e.g. creatine deficiencies). 
Creatine supplementation may improve the performance in some cognitive tasks, particularly in 
stressful conditions (e.g. mental fatigue, exhaustive exercise). 
What is unknown: 
Can creatine supplementation increase brain creatine in healthy individuals? 
If so: 
(a) To what extent? 
(b) In which brain region? 
(c) What is the ratio of responders: non-responders and which factors determine 
responsiveness? 
(d) What the ideal supplementation protocol? 
Can creatine supplementation improve cognitive function in healthy individuals under non-
stressful conditions? 
Can creatine supplementation enhance recovery from, or reduce the severity of, mild traumatic 
brain injury? 
The effects of creatine supplementation on brain function appear to be larger under stressful 
conditions that lead to acute (e.g. mental fatigue, exhaustive exercise) or chronic (e.g. aging, 
depression, post-traumatic stress disorder) depletion of brain creatine (see Figure 1), whereas no 
or minimal effect is shown in healthy individual under unstressed conditions. The exact 
circumstances and populations in which brain creatine is decreased should be determined as they 
are potential targets for creatine supplementation. Finally, although there appears to be a sound 
mechanistic basis for creatine supplementation to reduce severity of or enhance recovery from 
mTBI, which is supported by the animal data available, few data are available that demonstrate a 
protective effect in humans. If an athlete already ingests creatine supplements for a different 
reason (e.g. sport performance), and mTBI brain injury is a possibility in their sport, ingesting 
creatine may offer them brain benefits as well. Additionally, creatine supplements are widely 
available, inexpensive, and have a very good safety profile (Gualano et al., 2011, 2012; Hayashi 
et al., 2014; Lugaresi et al., 2013; Pereira et al., 2015; Persky & Rawson, 2007; Rawson, 
Clarkson, & Tarnopolsky, 2017), which also favours the decision to recommend creatine 
supplementation to athletes at higher risks of mTBI. Creatine may also be considered for other 
stressful situations whereby acute creatine reductions are likely to occur. As described above, 
creatine may offset the negative cognitive effects of sleep deprivation. There are a number of 
situations where this may be particularly relevant, and thus where creatine supplementation may 
be particularly efficacious. For example, athletes competing in multi-day tournaments have high 
requirements to maintain optimal cognitive functioning, however, sleep deprivation due to travel 
requirements, unfamiliar surroundings and intensive schedules is likely. In these situations, 
cognitive function may be enhanced or maintained through supplementation. Similarly, sleep 
deprivation and anxiety are common among students during exam periods, a time when optimal 
cognitive processing is essential. Finally, many cognitively demanding occupations require 
individuals to work over-night shifts and/or very long hours, e.g. medical personnel or pilots 
frequently work very long or unusual hours, and thus to have disrupted sleep patterns, however 
they may also be required to make important and at times vital decisions, and thus to require 
optimal cognitive processing. Individuals who are required to make important decisions under 
potentially stressful situations, particularly those characterized by disrupted sleep patterns, may 
therefore, benefit from the cognitive enhancing properties of creatine supplementation. 
PHOTO (COLOR): Figure 1. Situations where creatine supplementation may enhance brain 
function. Panel A: Acute stressors, e.g. sleep deprivation, exhaustive exercise, acute hypoxia, 
cognitively demanding tasks or mTBI can cause a reduction in brain creatine, thus impacting 
brain function. Preventive supplementation creates a 'reserve' of brain creatine, protecting against 
the reduction caused by anticipated acute stressors, facilitating maintenance of usual brain 
function. Panel B: Some conditions are associated with chronically reduced brain creatine, e.g. 
cerebral creatine deficiency syndromes, depression, schizophrenia or senescence. Therapeutic 
creatine supplementation restores brain creatine content, facilitating recovery of usual brain 
function. 
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